Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2021-12-08 | 2021-12-08 |
| Drug Identification Number | 02416808 | 02416808 |
| Brand name | JANUMET XR | JANUMET XR |
| Common or Proper name | sitagliptin and metformin hydrochloride modified-release tablets | sitagliptin and metformin hydrochloride modified-release tablets |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | METFORMIN HYDROCHLORIDE SITAGLIPTIN | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 1000MG 100MG | 1000MG 100MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 30 | 30 |
| ATC code | A10BD | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2021-12-14 | 2021-12-14 |
| Actual start date | ||
| Estimated end date | 2021-12-20 | 2021-12-17 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Expected shortage due to quality testing delay. | Expected shortage due to testing delay. |
| Health Canada comments |